[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100560703":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":37,"responsibleParty":58,"collaborators":61,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":74,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":18,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Queen's University, Belfast","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"OCS","ACTIVE_COMPARATOR","To receive OCS (this is standard of care as the children will be recruited if their is clinicial uncertainty over the benefit of OCS, i.e. this is not a CTIMP). The local policy is to prescribe Dexamethasone suspension 300mcg\u002Fkg in a single dose.",[13],"Diagnostic Test: Point of care respiratory virus testing",{"label":15,"type":16,"description":17,"interventionNames":18},"No OCS","NO_INTERVENTION","The child will not recieve any cortisteroid medications (this is standard of care as the children will be recruited if their is clinicial uncertainty over the benefit of OCS, i.e. this is not a CTIMP).",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","Point of care respiratory virus testing","Patients to be randomised to receive OCS based on the the result of the RSV results within their respiratory virus test. This test will be performed as a point of care (POC) test in ED.\n\nThis intervention will stratify the randomisation in a 1:1 ratio, to receive OCS or not.\n\nNB) Whilst the respiratory pathogen test is not routine care to determine the OCS prescription, it is frequently used within this setting. Additionally both the receipt (or not the receipt) of OCS is within standard care pathway. For the purpose of the trial OCS = Dexamethasone, which is delivered as oral suspension 300mcg\u002Fkg as per standard practice within the local Trust.",[9],[26],"RSV test",[28],{"name":29,"affiliation":5,"role":30},"Helen E Groves, PhD","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":35,"phoneExt":18,"email":36},"Hannah R Norman-Bruce, MBBS","CONTACT","(+44) 028 9097 1643","hnormanbruce01@qub.ac.uk",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Royal Belfast Hospital for Sick Children","RECRUITING","Belfast","NI","BT12 6BA","United Kingdom","UK",{"type":47,"coordinates":48},"Point",[49,50],-5.92541,54.59682,{"lat":50,"lon":49},[53,56],{"name":54,"role":34,"phone":55,"phoneExt":18,"email":36},"Hannah Norman - Bruce, MBBS","+447905795231",{"name":57,"role":30,"phone":18,"phoneExt":18,"email":18},"Tom Waterfield, PhD",{"type":30,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Thomas Waterfield","Clinical Lecturer in Paediatrics",[62,64],{"name":63,"class":6},"Asthma UK",{"name":65,"class":6},"Pediatric Emergency Research in the UK and Ireland (PERUKI)","100560703","precision-medicine-directed-corticosteroids-in-children-with-preschool-wheeze-100560703",false,"NCT06580600","PREcision Medicine Directed Corticosteroids In Children With preSchool Wheeze","A Single Centre Randomised, Feasibility Study Using Point-of-care (POC) Testing for Respiratory Viruses to Direct Oral Corticosteroids Use in Preschool-aged Children With Acute Wheeze.","PRECISE","Inclusion Criteria:\n\n* 24-60 months (infants from 24 months +0 days to 60 months + 0 days inclusive)\n* Clinical diagnosis of acute wheeze\n* Clinical uncertainty regarding the benefit of OCS as part of patient's standard care\n\nExclusion Criteria:\n\n* Signs and symptoms of severe or life-threatening wheeze\n* Patients presenting with wheeze suspicious for a non - respiratory cause\n* Clinical evidence of shock or bacterial sepsis\n* Past history of severe or life-threatening asthma or history of previous PICU admission with acute wheeze\n* History of preterm birth (before 36+0 weeks gestation)\n* Known immunodeficiency\u002Fongoing immunosuppressive therapy\n* Contraindication to oral corticosteroids\n* Previously enrolled in the PRECISE Study",true,"ALL","24 Months","60 Months",{"count":79,"type":80},120,"ESTIMATED","INTERVENTIONAL",[83],"NA","Young children frequently attend the emergency department (ED) with wheeze which is usually triggered by a virus infection, such as the common cold. Wheeze can be treated with inhaled medications and sometimes oral steroid medicines are also given to reduce swelling within the lungs. Unfortunately, oral steroids can have side effects. Despite lots of research there is no clear evidence that oral steroids work in young children with a wheeze attack. It is likely that some children get better quicker with oral steroids but deciding who to treat is difficult. This results in differences in care with some children receiving unnecessary oral steroids and others not receiving them when they could benefit.\n\nThe investigators hypothesise that in a subgroup of children with mild-to-moderate acute wheeze attacks, the viral trigger can predict their response to steroid medications. Previously, respiratory virus testing was too slow to be used to inform treatments in the ED. Now, point-of-care (POC) viral tests can provide results within 30 minutes. There is a research gap regarding the role of these tests in determining steroid responsiveness and outcomes in children presenting with acute wheeze in the pre-school population.\n\nIn order to address the hypothesis in a future definitive trial, the feasibility of using (POC) viral tests to randomise steroid treatments for children in a clinical study in the ED setting must be ascertained. The PRECISE Study will therefore be a single centre randomised, feasibility study enrolling approximately 60 pre-school aged children to inform a future definitive multi-centre Randomised Controlled Trial.",[86],"Wheezing",[88,89,90,91],"pre-school","wheeze","corticosteroid","point-of-care","2025-03-18",{"date":94,"type":95},"2025-03-21","ACTUAL",{"date":97,"type":95},"2024-11-04",{"date":99,"type":80},"2025-12-03",{"name":5,"class":6},1]